AI Portfolio Summary
In 2026 Q1, Exome Asset Management LLC maintained a portfolio of 83 distinct positions. The most significant new addition to the portfolio was SPDR SERIES TRUST, which now represents 3.96% of the total fund value. The fund also reduced its exposure to LIQUIDIA CORPORATION by 49.8%.
Total Positions
83
Quarter
2026 Q1
Top Holding
PRAX (7.6%)
Top 10 Concentration
42.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 83
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 7.58% | 8.19% |
#1
Prev: #1
|
5.0 | -12,653 | -21.8% |
P
S
|
45,469 | $14,649,657 |
$46.67
+565.1%
|
2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 5.54% | 5.19% |
#2
Prev: #2
|
4.2 | -27,035 | -8.8% |
P
S
|
278,533 | $10,720,735 |
$5.99
+487.8%
|
2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 4.46% | 1.64% |
#3
18
Prev: #21
|
3.3 | -2,217 | -1.0% |
P
S
|
220,091 | $8,627,567 |
$15.97
+143.2%
|
2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 4.27% | 4.41% |
#4
Prev: #4
|
2.7 | -6,451 | -5.5% |
P
S
|
110,064 | $8,264,706 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 3.96% | — |
#5
Prev: #—
|
5.6 | 60,000 | no change |
NEW
|
60,000 | $7,663,800 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 3.95% | 4.79% |
#6
3
Prev: #3
|
2.1 | -15,446 | -15.7% |
P
S
|
82,736 | $7,642,324 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.54% | 3.79% |
#7
1
Prev: #6
|
1.9 | -21,031 | -16.9% |
P
S
|
103,718 | $6,836,053 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 3.34% | 4.03% |
#8
3
Prev: #5
|
1.8 | -840 | -10.7% |
P
S
|
7,012 | $6,449,427 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 3.18% | 1.36% |
#9
22
Prev: #31
|
1.8 | -13,074 | -4.5% |
P
S
|
279,176 | $6,150,247 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.59% | 2.95% |
#10
1
Prev: #9
|
1.5 | -13,231 | -16.4% |
P
S
|
67,492 | $5,011,956 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.39% | 3.01% |
#11
3
Prev: #8
|
1.5 | -9,400 | -7.6% |
P
S
|
114,991 | $4,626,088 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSM
INSMED INC
|
Healthcare | 2.25% | — |
#12
Prev: #—
|
4.4 | 26,651 | no change |
NEW
|
26,651 | $4,357,972 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 2.22% | 2.88% |
#13
3
Prev: #10
|
1.4 | -2,514 | -14.6% |
P
S
|
14,677 | $4,296,692 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 2.19% | 1.78% |
#14
3
Prev: #17
|
1.4 | -11,882 | -8.7% |
P
S
|
125,060 | $4,230,780 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.16% | 1.79% |
#15
1
Prev: #16
|
1.4 | -632 | -8.2% |
P
S
|
7,053 | $4,182,288 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 2.08% | — |
#16
Prev: #—
|
4.3 | 215,376 | no change |
NEW
|
215,376 | $4,014,609 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
CYTOKINETICS IN...
|
—
|
PUT Option | 2.05% | — |
#17
Prev: #—
|
4.3 | 60,000 | no change |
NEW
|
60,000 | $3,954,600 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
NTRA
NATERA INC
|
Healthcare | 1.93% | 2.04% |
#18
5
Prev: #13
|
1.8 | no change | no change |
P
S
|
18,650 | $3,729,814 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.83% | — |
#19
Prev: #—
|
4.2 | 40,581 | no change |
NEW
|
40,581 | $3,529,330 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.80% | 0.92% |
#20
23
Prev: #43
|
3.7 | 7,027 | 120.4% |
P
S
|
12,862 | $3,480,329 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.78% | 1.63% |
#21
2
Prev: #23
|
0.7 | -50,332 | -37.0% |
P
S
|
85,517 | $3,440,349 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 1.75% | 1.48% |
#22
7
Prev: #29
|
3.7 | 234,957 | 58.5% |
P
S
|
636,700 | $3,374,510 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 1.69% | 1.28% |
#23
10
Prev: #33
|
1.2 | -9,464 | -5.8% |
P
S
|
154,194 | $3,273,539 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.57% | — |
#24
Prev: #—
|
4.1 | 48,347 | no change |
NEW
|
48,347 | $3,033,774 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.54% | — |
#25
Prev: #—
|
4.1 | 84,103 | no change |
NEW
|
84,103 | $2,973,882 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CALL
BEONE MEDICINES...
|
—
|
CALL Option | 1.54% | — |
#26
Prev: #—
|
4.1 | 10,000 | no change |
NEW
|
10,000 | $2,969,700 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 1.53% | — |
#27
Prev: #—
|
4.1 | 179,484 | no change |
NEW
|
179,484 | $2,952,512 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.52% | 1.72% |
#28
9
Prev: #19
|
1.6 | no change | no change |
P
S
|
6,358 | $2,930,974 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ADAG
ADAGENE INC
|
Healthcare | 1.49% | 0.96% |
#29
12
Prev: #41
|
0.6 | -323,376 | -30.5% |
P
S
|
736,845 | $2,888,432 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.48% | 1.58% |
#30
4
Prev: #26
|
1.1 | -4,037 | -8.1% |
P
S
|
45,721 | $2,866,707 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CRESCENT BIOPHA...
|
—
|
Unknown | 1.46% | — |
#31
Prev: #—
|
4.1 | 153,191 | no change |
NEW
|
153,191 | $2,814,119 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.43% | — |
#32
Prev: #—
|
4.1 | 278,302 | no change |
NEW
|
278,302 | $2,769,105 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.37% | — |
#33
Prev: #—
|
4.0 | 88,510 | no change |
NEW
|
88,510 | $2,642,024 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 1.27% | 1.52% |
#34
7
Prev: #27
|
0.5 | -223,837 | -30.0% |
P
S
|
521,468 | $2,450,900 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.23% | — |
#35
Prev: #—
|
4.0 | 159,341 | no change |
NEW
|
159,341 | $2,378,961 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
ALUMIS INC
|
—
|
PUT Option | 1.20% | 0.25% |
#36
19
Prev: #55
|
3.5 | 51,800 | 97.4% |
P
S
|
105,000 | $2,313,150 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
GKOS
GLAUKOS CORP
|
Healthcare | 1.16% | 1.70% |
#37
17
Prev: #20
|
0.5 | -10,597 | -33.7% |
P
S
|
20,874 | $2,247,295 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.14% | 0.54% |
#38
13
Prev: #51
|
3.5 | 94,593 | 67.8% |
P
S
|
234,136 | $2,198,537 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PEN
PENUMBRA INC
|
Healthcare | 1.07% | 1.34% |
#39
7
Prev: #32
|
0.4 | -2,700 | -30.0% |
P
S
|
6,300 | $2,068,731 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 1.07% | — |
#40
Prev: #—
|
3.9 | 61,673 | no change |
NEW
|
61,673 | $2,064,812 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 0.89% | 1.50% |
#41
13
Prev: #28
|
0.4 | -45,352 | -49.8% |
P
S
|
45,796 | $1,728,341 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.82% | — |
#42
Prev: #—
|
3.8 | 80,730 | no change |
NEW
|
80,730 | $1,578,272 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
LIQUIDIA CORPOR...
|
—
|
PUT Option | 0.78% | — |
#43
Prev: #—
|
3.8 | 40,000 | no change |
NEW
|
40,000 | $1,509,600 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
IMAB
NOVABRIDGE BIOS...
|
Unknown | 0.73% | 0.95% |
#44
2
Prev: #42
|
2.3 | 77,373 | 15.5% |
P
S
|
576,960 | $1,419,322 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
CENTESSA PHARMA...
|
—
|
PUT Option | 0.71% | — |
#45
Prev: #—
|
3.8 | 34,700 | no change |
NEW
|
34,700 | $1,378,284 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
PUT
IDEAYA BIOSCIEN...
|
—
|
PUT Option | 0.69% | — |
#47
Prev: #—
|
3.8 | 40,000 | no change |
NEW
|
40,000 | $1,332,800 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
CALL
IDEAYA BIOSCIEN...
|
—
|
CALL Option | 0.69% | — |
#46
Prev: #—
|
3.8 | 40,000 | no change |
NEW
|
40,000 | $1,332,800 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 0.63% | — |
#48
Prev: #—
|
3.8 | 130,564 | no change |
NEW
|
130,564 | $1,215,551 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.63% | 1.12% |
#49
13
Prev: #36
|
0.3 | -49,500 | -30.0% |
P
S
|
115,500 | $1,215,060 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.54% | 0.85% |
#50
6
Prev: #44
|
0.2 | -158,203 | -20.9% |
P
S
|
600,000 | $1,050,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 83 holdings